Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - ENDOLOGIX INC /DE/ | elgx_ex322x9302017-q2.htm |
| EX-31.2 - EXHIBIT 31.2 - ENDOLOGIX INC /DE/ | elgx_ex312x9302017-q2.htm |
| EX-31.1 - EXHIBIT 31.1 - ENDOLOGIX INC /DE/ | elgx_ex311x9302017-q2.htm |
| EX-10.1 - EXHIBIT 10.1 - ENDOLOGIX INC /DE/ | elgx_ex101jonopcx9302017-q3.htm |
| 10-Q - 10-Q - ENDOLOGIX INC /DE/ | elgx_9302017-10q.htm |
Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to 18 U.S.C Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, John McDermott, certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 that:
(1) | The Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2017 (the “Quarterly Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 780(d)); and |
(2) | The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: | November 7, 2017 | By: | /s/ John McDermott |
John McDermott | |||
Chief Executive Officer | |||
This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.